I was diagnosed end of April 2017, chemo, then radiation took me through to January 2018, Surgery start of February 2018, commenced with Xeloda exactly 4 weeks after surgery. At the time of being prescribed, both my oncologist and surgeon said it was a very new way in which they were using an existing drug for TNBC to avoid recurrence. I am very grateful to them for being at the forefront of latest treatment knowledge and that the drug is funded under the Pharmaceutical Benefits Scheme.
Jen